ITRM910519A1 - Collirio per il trattamento della ipertensione oculare - Google Patents

Collirio per il trattamento della ipertensione oculare

Info

Publication number: ITRM910519A1
Authority: IT; Italy
Prior art keywords: optionally; inhibitors; combinations; group; range
Prior art date: 1991-07-12

Application number

IT000519A

Other languages

English (en)

Inventor

Ciro Costagliola

Original Assignee

Ciro Costagliola

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-12

Filing date

1991-07-12

Publication date

1993-01-12

1991-07-12 Application filed by Ciro Costagliola filed Critical Ciro Costagliola

1991-07-12 Priority to ITRM910519A priority Critical patent/IT1249678B/it

1991-07-12 Publication of ITRM910519A0 publication Critical patent/ITRM910519A0/it

1991-12-20 Priority to EP91830581A priority patent/EP0522226B1/en

1991-12-20 Priority to AT91830581T priority patent/ATE157872T1/de

1991-12-20 Priority to DE69127619T priority patent/DE69127619D1/de

1991-12-27 Priority to JP3361478A priority patent/JPH0525047A/ja

1993-01-12 Publication of ITRM910519A1 publication Critical patent/ITRM910519A1/it

1995-03-09 Application granted granted Critical

1995-03-09 Publication of IT1249678B publication Critical patent/IT1249678B/it

Links

206010020772 Hypertension Diseases 0.000 title 1
239000003112 inhibitor Substances 0.000 abstract 2
FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 abstract 2
229960005417 ketanserin Drugs 0.000 abstract 2
239000000243 solution Substances 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 abstract 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
102000003846 Carbonic anhydrases Human genes 0.000 abstract 1
108090000209 Carbonic anhydrases Proteins 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
206010030043 Ocular hypertension Diseases 0.000 abstract 1
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 abstract 1
229920002125 Sokalan® Polymers 0.000 abstract 1
239000002160 alpha blocker Substances 0.000 abstract 1
229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 abstract 1
229940089206 anhydrous dextrose Drugs 0.000 abstract 1
229960000686 benzalkonium chloride Drugs 0.000 abstract 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
239000002876 beta blocker Substances 0.000 abstract 1
229940097320 beta blocking agent Drugs 0.000 abstract 1
239000007853 buffer solution Substances 0.000 abstract 1
239000003283 colorimetric indicator Substances 0.000 abstract 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
229910000397 disodium phosphate Inorganic materials 0.000 abstract 1
235000019800 disodium phosphate Nutrition 0.000 abstract 1
239000003889 eye drop Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
229940031574 hydroxymethyl cellulose Drugs 0.000 abstract 1
229920003063 hydroxymethyl cellulose Polymers 0.000 abstract 1
229910000402 monopotassium phosphate Inorganic materials 0.000 abstract 1
235000019796 monopotassium phosphate Nutrition 0.000 abstract 1
230000003204 osmotic effect Effects 0.000 abstract 1
229960001416 pilocarpine Drugs 0.000 abstract 1
239000004584 polyacrylic acid Substances 0.000 abstract 1
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 abstract 1
LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000001488 sodium phosphate Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Devices For Medical Bathing And Washing (AREA)

ITRM910519A 1991-07-12 1991-07-12 Collirio per il trattamento della ipertensione oculare IT1249678B (it)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
ITRM910519A IT1249678B (it)	1991-07-12	1991-07-12	Collirio per il trattamento della ipertensione oculare
EP91830581A EP0522226B1 (en)	1991-07-12	1991-12-20	Eyedrop solution for the treatment of ocular hypertension containing ketauserin
AT91830581T ATE157872T1 (de)	1991-07-12	1991-12-20	Ketanserin enthaltende augentropfen zur behandlung von intraokularem druck
DE69127619T DE69127619D1 (de)	1991-07-12	1991-12-20	Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck
JP3361478A JPH0525047A (ja)	1991-07-12	1991-12-27	高眼圧の治療用の点眼溶液

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITRM910519A IT1249678B (it)	1991-07-12	1991-07-12	Collirio per il trattamento della ipertensione oculare

Publications (3)

Publication Number	Publication Date
ITRM910519A0 ITRM910519A0 (it)	1991-07-12
ITRM910519A1 true ITRM910519A1 (it)	1993-01-12
IT1249678B IT1249678B (it)	1995-03-09

Family

ID=11400263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ITRM910519A IT1249678B (it)	1991-07-12	1991-07-12	Collirio per il trattamento della ipertensione oculare

Country Status (5)

Country	Link
EP (1)	EP0522226B1 (it)
JP (1)	JPH0525047A (it)
AT (1)	ATE157872T1 (it)
DE (1)	DE69127619D1 (it)
IT (1)	IT1249678B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69710258T2 (de) *	1996-06-17	2002-08-22	Mitsubishi Chemical Corp., Tokio/Tokyo	Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle
US6960579B1 (en)	1998-05-19	2005-11-01	Alcon Manufacturing, Ltd.	Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
DE69928542T2 (de)	1998-09-18	2006-03-30	Alcon Manufacturing Ltd., Fort Worth	5HT2-Agonisten zur Behandlung des Glaukoms
US7005448B2 (en)	2001-12-14	2006-02-28	Alcon, Inc.	Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
AU2003243101B2 (en)	2002-07-19	2010-05-13	Biovitrum Ab (Publ)	Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
US9421175B2 (en)	2004-03-17	2016-08-23	Lars Michael Larsen	Prevention of retinopathy by inhibition of the visual cycle
IT201600072000A1 (it) *	2016-07-11	2018-01-11	Luigi Ambrosone	Collirio a base di liposomi e suo uso per la valutazione in vivo dell'efficacia farmacologica della terapia medica e chirurgica anti-glaucoma
SE2250051A1 (en) *	2022-01-20	2023-07-21	Amidea Sweden Ab	New pharmaceutical composition and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3751974T2 (de) *	1986-09-22	1997-04-10	Janssen Pharmaceutica Nv	Serotonin-Antagonisten zur Behandlung von Wunden
WO1991002527A1 (en) *	1989-08-21	1991-03-07	Beth Israel Hospital Association	Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

1991
- 1991-07-12 IT ITRM910519A patent/IT1249678B/it active IP Right Grant
- 1991-12-20 DE DE69127619T patent/DE69127619D1/de not_active Expired - Lifetime
- 1991-12-20 AT AT91830581T patent/ATE157872T1/de not_active IP Right Cessation
- 1991-12-20 EP EP91830581A patent/EP0522226B1/en not_active Expired - Lifetime
- 1991-12-27 JP JP3361478A patent/JPH0525047A/ja active Pending

Also Published As

Publication number	Publication date
DE69127619D1 (de)	1997-10-16
ITRM910519A0 (it)	1991-07-12
EP0522226A1 (en)	1993-01-13
JPH0525047A (ja)	1993-02-02
IT1249678B (it)	1995-03-09
ATE157872T1 (de)	1997-09-15
EP0522226B1 (en)	1997-09-10

Legal Events

Date	Code	Title	Description
1995-03-09	0001	Granted
1999-10-27	TA	Fee payment date (situation as of event date), data collected since 19931001	Effective date: 19971031

Publication	Publication Date	Title
US6291466B1 (en)	2001-09-18	Cholinergic agents in the treatment of presbyopia
RU2004134733A (ru)	2005-05-10	Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий
ATE265856T1 (de)	2004-05-15	Augenlösung mit tetracyclin für behandlung von trockenen augen
ITRM910519A1 (it)	1993-01-12	Collirio per il trattamento della ipertensione oculare
Perry et al.	1993	Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model: preliminary observations
CA2029657C (en)	2002-06-18	Compositions and their use in lowering intraocular pressure
DK593989A (da)	1990-05-30	Vandige oejenoploesninger og fremgangsmaade til konservering heraf
US6037368A (en)	2000-03-14	8-iso- prostaglandins for glaucoma therapy
DK0495421T3 (da)	1996-12-09	Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
US4594091A (en)	1986-06-10	Borate algaecide and fungicide
NO931980L (no)	1993-12-03	Angiotensin II-antagoniserende imidazolderivater, deres fremstilling og terapeutiske anvendelse
CA2326339A1 (en)	1999-10-07	Use of dexmedetomidine for icu sedation
US4996209A (en)	1991-02-26	Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen
IE891118L (en)	1989-10-08	Topical preparation for treating otopathy
US5131938A (en)	1992-07-21	Borate algaecide and fungicide
EP0114333B1 (en)	1990-08-29	Pharmaceutical composition
CA1246457A (en)	1988-12-13	Method of treating cardiac insufficiency
US5965620A (en)	1999-10-12	Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA1265055A (en)	1990-01-30	Pharmaceutical preparation
US5620970A (en)	1997-04-15	Topical ophthalmic carbonic anhydrase inhibitor formulations
RU2009120545A (ru)	2010-12-10	Модуляторы связывания pai-1 для лечения глазных болезней
Wikman-Coffelt et al.	1975	Comparison of mild vs severe pressure overload on the enzymatic activity of myosin in the canine ventricles
CA2310230C (en)	2008-05-06	The use of brinzolamide to prevent visual field loss
CA2240271A1 (en)	1997-07-03	Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
US4826812A (en)	1989-05-02	Antiglaucoma agent